Syantra
Calgary
About Syantra
Syantra is a precision biotechnology company that transforms cancer detection and treatment. The company is initially targeting breast cancer detection and treatment, highlighting its commitment to combatting this prevalent disease. Syantra''s flagship product, Syantra DX™ Breast Cancer, is a blood test designed for early breast cancer screening. This test measures a panel of gene expression biomarkers from whole blood and utilizes machine learning algorithms to interpret the data, providing a positive or negative result. Clinical studies have demonstrated high inferred accuracy for women under 50 and overall. Syantra's Onco-ID™ platform aims to expand early cancer detection capabilities across multiple cancer types.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.4M
- Last round: Undisclosed (Sep 2025)
- Website: syantra.com
- Phone: +1 877-331-0516
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/syantra-96567 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.